Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Eiman Shafa

Orthopaedic Surgery of the Spine Minneapolis, MN Medical Doctor

NPI 1215258462 CMS profile 1394775

913 E 26Th St Ste 600, Ste 600, Minneapolis, MN 55404

Open in the dashboard

General payments

$569,635

681 records reported · program years 2019–2025

Research payments

$650

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Eiman Shafa of Minneapolis, MN is reported in the CMS Open Payments database as having received $569,635 across 681 general payments and $650 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 91st percentile of Orthopaedic Surgery of the Spine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $48,742 67
2024 General $120,529 143
2023 General $96,140 114
2023 Research $650 1
2022 General $107,239 133
2021 General $144,328 121
2020 General $46,684 52
2019 General $5,971 51

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Eiman Shafa
  • Orthopaedic Surgery of the Spine median
  • Middle half of Orthopaedic Surgery of the Spine
  • National median

In program year 2025, general payments to Eiman Shafa were reported at $48,742. Among 1,704 Orthopaedic Surgery of the Spine profiles paid that year, the median was $2,061 and the middle half received between $347 and $14,651.

Show as a table
Year Eiman Shafa Orthopaedic Surgery of the Spine median Middle half National median
2019 $5,971 $2,106 $337–$18,608 $163
2020 $46,684 $1,213 $156–$15,082 $114
2021 $144,328 $1,834 $271–$15,617 $132
2022 $107,239 $2,015 $320–$17,036 $149
2023 $96,140 $1,925 $336–$14,599 $160
2024 $120,529 $2,110 $341–$12,483 $164
2025 $48,742 $2,061 $347–$14,651 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic, Inc. $368,779 356 payments
  2. Medical Device Business Services, Inc. $127,295 120 payments
  3. Medtronic USA, Inc. $44,787 72 payments
  4. DePuy Synthes Products, Inc. $15,038 31 payments
  5. Kuros Biosciences USA, Inc $6,674 8 payments
  6. DePuy Synthes Sales Inc. $1,400 30 payments
  7. Carlsmed, Inc. $1,143 7 payments
  8. Stryker Corporation $1,068 4 payments
  9. Globus Medical, Inc. $894 6 payments
  10. Arthrex, Inc. $581 12 payments
  11. Other $1,976 35 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $269,562 60 payments
  2. Consulting Fee $232,499 65 payments
  3. Travel and Lodging $52,675 226 payments
  4. Food and Beverage $14,768 318 payments
  5. Education $130 12 payments
Products named General payments · program years 2019–2025
  1. MAZOR X SYSTEM $144,646 128 payments
  2. Mazor X Stealth Edition $75,940 88 payments
  3. MazorX - Renaissance $18,604 24 payments
  4. STEALTHSTATION S8 PLATFORM $15,984 17 payments
  5. ANTERALIGN SPINAL SYSTEM WITH TITAN NANOLOCK SURFACE TECHNOLOGY $15,784 11 payments
  6. POWEREASE $15,273 2 payments
  7. CD HORIZON SPINAL SYSTEM $8,723 29 payments
  8. StealthStation $7,775 6 payments
  9. MAGNETOS $6,674 8 payments
  10. CONDUIT $5,570 30 payments
  11. Other $38,560 217 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Medtronic, Inc. $650 1 payment

Prescribing to Medicare patients

Part D · data year 2024 · 5 drugs

Part D claims

209

Median for Orthopedic Surgery: 203

Drug cost

$1,103

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Gabapentin Generic 51 $426
Methocarbamol Generic 95 $415
Cyclobenzaprine Hcl Generic 31 $145
Methylprednisolone Generic 18 $92
Tizanidine Hcl Generic 14 $26

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 58 billing codes

Paid by Medicare

$128,803

Medicare's payments for the services billed

Medicare patients

160

Average age 71

Services billed

463

95 women, 65 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 68%
Depression 37%
Chronic kidney disease 27%
Diabetes 24%
Ischemic heart disease 24%
Atrial fibrillation 16%
Heart failure 15%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

682 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery of the Spine in Minnesota

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record